Xeris Pharmaceuticals, Inc. Banner Image

Xeris Pharmaceuticals, Inc. has reached its limit for free report views

Work for Xeris Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Xeris Pharmaceuticals, Inc.

  • Ticker XERS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Xeris Pharmaceuticals, Inc. Logo Image
  • 51-200 Employees
  • Based in Chicago, Illinois
Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, room-temperature stable injectable and infusible drug formulations. The Company’s proprietary XeriSol™ and XeriJect™ formulation technologies are being evaluated for the subcutaneous (SC) and intramuscular (IM) delivery of highly-concentrated, non-aqueousMore, ready-to-use formulations of peptides, small molecules, proteins, and antibodies using commercially available syringes, auto-injectors, multi-dose pens, and infusion pumps. XeriSol™ and XeriJect™ have the potential to offer distinct advantages over existing formulations of marketed and development-stage products, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. These attributes may lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.
Xeris Pharmaceuticals, Inc.

Most Recent Annual Report

Xeris Pharmaceuticals, Inc.
MOST RECENT 2021 Annual Report, 2020 Form 10K

Report Locked. Xeris Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports